PT - JOURNAL ARTICLE AU - Yanfang Peipei Zhu AU - Tobias Eggert AU - Daniel J Araujo AU - Pandurangan Vijayanand AU - Christian Hermann Ottensmeier AU - Catherine C Hedrick TI - CyTOF mass cytometry reveals phenotypically distinct human blood neutrophil populations differentially correlated with melanoma stage AID - 10.1136/jitc-2019-000473 DP - 2020 Sep 01 TA - Journal for ImmunoTherapy of Cancer PG - e000473 VI - 8 IP - 2 4099 - http://jitc.bmj.com/content/8/2/e000473.short 4100 - http://jitc.bmj.com/content/8/2/e000473.full SO - J Immunother Cancer2020 Sep 01; 8 AB - Background Understanding neutrophil heterogeneity and its relationship to disease progression has become a recent focus of cancer research. Indeed, several studies have identified neutrophil subpopulations associated with protumoral or antitumoral functions. However, this work has been hindered by a lack of widely accepted markers with which to define neutrophil subpopulations.Methods To identify markers of neutrophil heterogeneity in cancer, we used single-cell cytometry by time-of-flight (CyTOF) coupled with high-dimensional analysis on blood samples from treatment-naïve patients with melanoma.Results Our efforts allowed us to identify seven blood neutrophil clusters, including two previously identified individual populations. Interrogation of these neutrophil subpopulations revealed a positive trend between specific clusters and disease stage. Finally, we recapitulated these seven blood neutrophil populations via flow cytometry and found that they exhibited diverse capacities for phagocytosis and reactive oxygen species production in vitro.Conclusions Our data provide a refined consensus on neutrophil heterogeneity markers, enabling a prospective functional evaluation in patients with solid tumors.